|
⚲
|
| Keyboard |
| Andera Partners
✚
|
|
|---|---|
| CIK # | 0001757283 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Kestra Medical Technologies Ltd | 53.7 | ||
| Evommune Inc | 43.6 | ||
| Mineralys Therapeutics Inc | 43.1 | ||
| Inventiva Sa | 10.1 | ||
| Abivax Sa | 8.7 | ||
| Nyxoah Sa | 1.5 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001757283] | |
| 3 | [0001757283] | |
| 4 | [0001757283] | |
| SC 13D | [0001757283] | |
| SC 13G | [0001757283] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BioDiscovery 4 FCPR | |
| Andera Partners | |
| Axonics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axonics Inc AXNX
Common Stock
|
2020-01-22 | Sell | 135,261 | $31.54 | 4,266,132 |
|
Axonics Inc AXNX
Common Stock
|
2020-01-17 | Sell | 164,739 | $31.51 | 5,190,926 |
|
Axonics Inc AXNX
Common Stock
|
2019-11-22 | Sell | 300,000 | $20.74 | 6,222,000 |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 431,250 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 654,237 | ||
|
Axonics Inc AXNX
Series C Preferred Stock · derivative
|
2018-11-02 | Conversion | 545,197 | $0.00 | |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 806,080 | ||
|
Axonics Inc AXNX
Series A Preferred Stock · derivative
|
2018-11-02 | Conversion | 345,000 | $0.00 | |
|
Axonics Inc AXNX
Series B-1 Preferred Stock · derivative
|
2018-11-02 | Conversion | 671,733 | $0.00 | |
|
Axonics Inc AXNX
Series B-2 Preferred Stock · derivative
|
2018-11-02 | Conversion | 359,375 | $0.00 | |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 799,228 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Buy | 866,666 | $15.00 | 12,999,990 |